1
|
Dewey RS, Ward C, Junor A, Horobin A. Talk to us! Communication is a key factor in improving the comfort of MRI research participants. Health Expect 2021; 24:1137-1144. [PMID: 33949066 PMCID: PMC8369077 DOI: 10.1111/hex.13217] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2020] [Revised: 01/12/2021] [Accepted: 02/03/2021] [Indexed: 01/22/2023] Open
Abstract
Context Magnetic resonance imaging (MRI) is an invaluable diagnostic and research tool. Having an MRI scan is not always comfortable and may deter people from taking part in MRI research. Maximizing comfort during scanning will improve participants’ experiences and image quality. Objective To define which factors improve comfort during an MRI scan for research by asking people who have participated in MRI research. Setting and participants People who had participated in MRI research during the past two years were invited, as ‘public advisors’ to discuss their experiences together and agree on which factors are most important in ensuring comfort while participating in MRI research. Results Public advisors ranked researcher‐participant communication as the most important factor. In response, an example script to guide MRI researchers in communicating with participants was developed through close consultation between research staff, public advisors and the public. This outlines the often‐missing information necessary to convey to participants, including explaining the reasons behind instructions, managing expectations, providing reassurance, encouragement and progress updates during scanning. Conclusions Drawing upon personal experiences as MRI research participants, public advisors highlighted the importance of effective and on‐going researcher communication throughout. The example script may be used as a training tool for researchers to help ensure participants’ comfort during scanning. Patient and public contribution All contributors had previously taken part in MRI research. The project was co‐designed, co‐delivered and co‐authored with a public research partner. Public advisors agreed key factors of importance. External public reviewers and public advisors reviewed example script drafts.
Collapse
Affiliation(s)
- Rebecca S Dewey
- Sir Peter Mansfield Imaging Centre, School of Physics and Astronomy, University of Nottingham, Nottingham, UK.,National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham, UK.,Hearing Sciences, Division of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK
| | | | - Andrea Junor
- National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham, UK.,Radiological and Imaging Sciences, Division of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK
| | - Adele Horobin
- National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham, UK.,Nottingham University Hospitals NHS Trust, Queens Medical Centre, Derby Road, UK
| |
Collapse
|
2
|
Deroose CM, Lecouvet FE, Collette L, Oprea-Lager DE, Kunz WG, Bidaut L, Verhoeff JJC, Caramella C, Lopci E, Tombal B, de Geus-Oei LF, Fournier L, Smits M, deSouza NM. Impact of the COVID-19 crisis on imaging in oncological trials. Eur J Nucl Med Mol Imaging 2020; 47:2054-2058. [PMID: 32533240 PMCID: PMC7289713 DOI: 10.1007/s00259-020-04910-y] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Affiliation(s)
- Christophe M Deroose
- European Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium.
- Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium.
- Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
| | - Frédéric E Lecouvet
- European Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium
- Department of Radiology, Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium
| | - Laurence Collette
- European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium
| | - Daniela E Oprea-Lager
- European Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium
- Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers (VU University), Amsterdam, The Netherlands
| | - Wolfgang G Kunz
- European Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium
- Department of Radiology, University Hospital, LMU Munich, Munich, Germany
| | - Luc Bidaut
- European Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium
- College of Science, University of Lincoln, Lincoln, UK
| | - Joost J C Verhoeff
- European Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium
- Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
| | - Caroline Caramella
- European Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium
- Radiology Department, Hôpital Marie Lannelongue, Institut d'Oncologie Thoracique, Université Paris-Saclay, Le Plessis-Robinson, France
| | - Egesta Lopci
- European Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium
- Nuclear Medicine, Humanitas Clinical and Research Hospital - IRCCS, Rozzano, Milan, Italy
| | - Bertrand Tombal
- Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
| | - Lioe-Fee de Geus-Oei
- European Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium
- Department of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, Leiden, The Netherlands
| | - Laure Fournier
- European Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium
- Department of Radiology, AP-HP, Hôpital Européen Georges Pompidou, Université de Paris, Paris, France
| | - Marion Smits
- European Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium
- Department of Radiology & Nuclear Medicine, Erasmus MC - University Medical Centre Rotterdam, Rotterdam, The Netherlands
| | - Nandita M deSouza
- European Organisation for Research and Treatment of Cancer (EORTC) Imaging Group, Brussels, Belgium
- Cancer Research UK Imaging Centre, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust-Sutton, Sutton, UK
| |
Collapse
|